Clinical course, complications and treatment outcomes in Still’s disease: a 10-year single-centre cohort study
Authors' conclusion
This 10-year cohort demonstrates marked heterogeneity in Still's disease/sJIA. MAS and ILD frequently co-occur and indicate a more aggressive course.
Study context
- Population
- Patients with Still's disease/sJIA followed 2015–2025 at a tertiary paediatric rheumatology centre
- Participants
- 110 patients
- Outcome
- Complications and disease course
Methodological detailssingle-centre, observational, logistic regression
- Single-centre
- Observational
- Logistic regression
Main finding
As reported in the abstract
Macrophage activation syndrome (MAS) occurrence
36.7%
Interstitial lung disease (ILD) occurrence
8.2%
Observational data: associations, not effects.
Original publication
Clinical course, complications and treatment outcomes in Still’s disease: a 10-year single-centre cohort study. RMD Open. Published 12 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →